Liquidation Sale Rabbit Anti Human Grik2 Polyclonal Antigen Affinity Purified (pbs With 0.05% Sodium Azide And 40% Glycerol, Ph7.4) (ihc,elisa) Best Choice [Xbd74pKs]

Rabbit Anti Human GRIK2 Polyclonal Antibody

Introducing the Rabbit Anti Human GRIK2 Polyclonal Antibody, a powerful tool for researchers in the field of neuroscience. This highly purified antibody is designed for use in various analytical techniques, including Immunohistochemistry (IHC) and Enzyme-Linked Immunosorbent Assay (ELISA). The antibody is prepared using an antigen affinity purification process, ensuring a high level of specificity and purity. With its broad compatibility across human, mouse, and rat species, this antibody is a versatile choice for your research needs.

Product Specifications

The Rabbit Anti Human GRIK2 Polyclonal Antibody is formulated in a buffered solution containing PBS with 0.05% sodium azide and 40% glycerol, pH 7.4. This ensures optimal stability and compatibility with a wide range of laboratory procedures. The antibody is derived from rabbit and targets the GRIK2 protein, which is associated with various neurological conditions such as autosomal recessive non-syndromic intellectual disability and spinocerebellar ataxia 11. Key features of this product include:

• Host Species: Rabbit
• Species Compatibility: Human, Mouse, Rat

The immunogen used is a synthetic peptide of human GRIK2, ensuring high specificity and sensitivity.

Applications and Benefits

The Rabbit Anti Human GRIK2 Polyclonal Antibody is ideal for use in both research and diagnostic settings. Its ability to be used in IHC and ELISA makes it a versatile tool for studying the function and expression of GRIK2 in various biological samples. This antibody can help researchers:

• Identify GRIK2 expression in tissue samples with high sensitivity
• Quantify GRIK2 levels using ELISA, enabling accurate measurements in various biological fluids

By using this antibody, researchers can gain valuable insights into the role of GRIK2 in neurological diseases and normal physiological processes, contributing to the development of new treatments and therapies.